Profile
Philippe Mendels-Flandre is the founder of Austral DX, serving as Chief Executive Officer since 2021.
Former positions include General Manager-Emerging Markets at Shire France SAS and Chief Operating Officer at Lysogene SA from 2017 to 2018.
Education includes an undergraduate degree from The Louvain School of Management.
Philippe Mendels-Flandre active positions
| Companies | Position | Start |
|---|---|---|
AUSTRAL Dx
AUSTRAL Dx Medical SpecialtiesHealth Technology Develops ultrasound-based diagnostic system for lung and cardiac diseases | Chief Executive Officer | 31/12/2020 |
Former positions of Philippe Mendels-Flandre
| Companies | Position | End |
|---|---|---|
| LYSOGENE | Chief Operating Officer | 14/11/2018 |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Training of Philippe Mendels-Flandre
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
The Louvain School of Management
The Louvain School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AUSTRAL Dx
AUSTRAL Dx Medical SpecialtiesHealth Technology Develops ultrasound-based diagnostic system for lung and cardiac diseases | Health Technology |
- Stock Market
- Insiders
- Philippe Mendels-Flandre
















